Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Late FDG-PET/CT Imaging Better Than Early FDG-PET/CT Imaging to Distinguish Between Malign and Inflammatory Changes in Lymph Nodes in Patients With Muscle Invasive Bladder Cancer Scheduled for Radical Cystectomy?

NCT03065725 is registered in ClinicalTrials.gov with Jørgen Bjerggaard Jensen as lead sponsor.

NCT NCT03065725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03065725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Late FDG-PET/CT Imaging Better Than Early FDG-PET/CT Imaging to Distinguish Between Malign and Inflammatory Changes in Lymph Nodes in Patients With Muscle Invasive Bladder Cancer Scheduled for Radical Cystectomy?
Lead sponsor
Jørgen Bjerggaard Jensen
Phase
Observational
Overall status
Completed
Start date
February 1, 2017
Completion date
January 1, 2022
Enrollment
179 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer